1974-1979: Corporate citizenship

Early on, we prioritized equal employment and instituted a minority-suppliers program, two initiatives that indicated our commitment to being good citizens of the world. In 1979, the Medtronic Foundation was established, reinforcing a commitment to corporate citizenship, the sixth tenet of our Mission. That same year, the Bakken Society was founded to recognize technical employees who make multiple, significant contributions to Medtronic, to the biomedical industry, and to customers and patients.



1987: Expansion into neurostimulation

Building on the science of using electrical stimulation to pace the heart, Medtronic collaborated with French doctors to pioneer the world’s first deep brain stimulation system to treat movement disorders.



2015: Covidien acquisition

Bringing together the extensive capabilities of Covidien and Medtronic strengthened our commitment to solve some of healthcare’s greatest challenges, enabling us to help treat more people, in more places, than ever before. 



2016: Breakthroughs in diabetes care

Our hybrid closed-loop system becomes the first FDA-approved device to automatically provide background insulin dosing 24-hours per day for people living with type 1 diabetes.



2024: Our legacy of life-transforming health tech

A lot has changed over the past 75 years, but our Mission to alleviate pain, restore health, and extend life continues to guide us. Click to watch.